Skip main navigation

Is no Prescribing Better than Back up/Delayed Prescribing?

Paul examines the data from the Cochrane review looking at six studies comparing back up/delayed antibiotic prescriptions to immediate antibiotics.
9
OK. Onto the systematic review now. Cochrane Review of Delayed Prescribing– is no prescribing actually a better thing to do? Well, there are six studies in that review that might have been updated more recently. But the message won’t have changed significantly. And as you can see immediate, lots of people end up using their antibiotics. They may not use all of them and keep some of them at home, but most of them will start using them anyway. Delayed prescription– they found around 28% to 30% will use their antibiotic. And certainly the most recent study that we did, the PIP Study, yeah, just over 30%, I would say, early to middle 30s will use them, which is fine.
50.9
If we could get all antibiotic use down to 30%, we’d be doing well. And in the Cochrane system, actually 4%– from our recent study, I would say that that’s on the low side. In the PIPs trial, it was in the mid 20s. So from our experience, there’s around a 10% to 15% difference in the number of people who will end up using an antibiotic if you use delayed prescription properly. The problem about the systematic review of delayed prescriptions done by Cochrane is that the number of studies is relatively few and very underpowered for looking at complications.
90.8
NICE, for their guidance, did some modelling, and basically they found– they suggested that delayed prescribing was the most efficient thing to do with lots of these respiratory infections. But it was based on some assumptions based on, basically, our sore throat trial.

Paul examines the data from the Cochrane review looking at six studies comparing back up/delayed antibiotic prescriptions to immediate antibiotics.

Cochrane Review of Delayed Prescribing

Using this systematic review, Paul asks ‘is no prescribing actually a better thing to do?’

The problem with the Cochrane review is that the number of studies is relatively few and very underpowered for looking at complications. This presentation will explore the outcome.

This article is from the free online

TARGET Antibiotics – Prescribing in Primary Care

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education